It’s been a busy year for 23andMe. Consumer DNA testing giant 23andMe. Less than five months after going public, the consumer genetic testing giant has made a major move to establish its position as a leader in DTC primary care by acquiring telehealth drug-delivery provider Lemonaid Health Inc. for $400 million. Here’s a look at…
23andMe Moves into Telehealth via $400 Million Lemonaid Acquisition
It’s been a busy year for 23andMe. Consumer DNA testing giant 23andMe. Less than five months after going public, the consumer genetic testing giant has made a major move to establish its position as a leader in DTC primary care by acquiring telehealth drug-delivery provider Lemonaid Health Inc. for $400 million. Here’s a look at […]
